Ono Collaborates with University of Oxford for Extensive Drug Discovery Partnership
Today, it was announced that Ono has initiated a comprehensive collaboration for drug discovery with the University of Oxford in Oxfordshire, UK. This collaboration aims to explore and validate drug…
Bio-Techne Attains European IVDR Certification for Diagnostic Test Monitoring Chronic Myeloid Leukemia
Bio-Techne Corporation (NASDAQ: TECH) has announced today that its Molecular Diagnostics Division, Asuragen, has successfully obtained Class C Certification under the new European Union In Vitro Diagnostic Regulation (IVDR) for…
WuXi Biologics Named to CDP ‘A List’ for Water Security
WuXi Biologics (2269.HK), a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), has proudly announced its recognition for exemplary corporate transparency and commitment to water security by the esteemed…
UCB’s BIMZELX[®]▼ (bimekizumab) Gains Favorable CHMP Opinion for treatment Moderate to Severe Hidradenitis Suppurativa in Adults
UCB, a leading global biopharmaceutical company, has announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a favorable opinion,…
Bayer and Trinity Agtech Collaborate to Advance Regenerative Agriculture Practices
In a strategic move towards advancing regenerative agriculture, Bayer has announced a partnership with Trinity Agtech, a UK-based company. This collaboration aims to leverage Trinity Agtech’s platform, Sandy, as a…
Legend Biotech Releases Debut Environmental, Social, and Governance (ESG) Report
Legend Biotech Corporation (NASDAQ: LEGN), a leading global figure in cell therapy, has unveiled its inaugural Environmental, Social & Governance (ESG) report. This comprehensive document provides an insight into Legend…
Viatris Announces Closure of Global Research and Development Collaboration with Idorsia: Official Statement
Viatris Inc. recently concluded agreements for a comprehensive global research and development collaboration with Idorsia Ltd (SIX: IDIA), a transaction that was finalized on March 15, 2024. For detailed information…
WuXi Biologics Commences Construction on CRDMO Facility in Singapore
WuXi Biologics announced a USD$1.4 billion (S$2 billion) investment in Singapore in 2022. The CRDMO center will be the first-of-its-kind in Singapore, offering end-to-end biologics research, development and manufacturing solutions…
Labcorp Introduces pTau217 Blood Test for Faster Alzheimer’s Diagnosis and Clinical Trial Support
Labcorp, a leading provider of cutting-edge laboratory services, has unveiled its latest breakthrough: a test capable of detecting phosphorylated tau 217 (pTau217) in the blood. This innovative biomarker serves as…
Dating a Person in Her 50s
A woman in her 50’s has frequently had enough knowledge in relationships to know what she wants and is n’t willing to settle. She is usually done making the same…
Pfizer Reports Encouraging Overall Survival Results in Phase 3 Study of ADCETRIS® Treatment for Relapsed/Refractory Diffuse Large B-cell Lymphoma
Pfizer Inc. (NYSE: PFE) has disclosed promising findings from a Phase 3 clinical trial investigating the efficacy of the antibody-drug conjugate ADCETRIS® (brentuximab vedotin) in conjunction with lenalidomide and rituximab…
Roche Annual General Meeting 2024
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced the successful approval of all proposed resolutions by its shareholders at the Annual General Meeting. The meeting saw 77.02% of the total…